Vardenafil improves satisfaction in couples affected by erectile dysfunction previously untreated with PDE5 inhibitors

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:177 / 177
页数:1
相关论文
共 50 条
  • [21] The impact of the use of PDE5 inhibitors for erectile dysfunction on the lives of Australian men
    H Matic
    M P McCabe
    [J]. International Journal of Impotence Research, 2007, 19 : 418 - 423
  • [22] Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil
    Choi, Min-Koo
    Song, Im-Sook
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (08) : 1074 - 1083
  • [23] Mechanisms of action of PDE5 inhibition in erectile dysfunction
    Corbin, JD
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (Suppl 1) : S4 - S7
  • [24] Mechanisms of action of PDE5 inhibition in erectile dysfunction
    J D Corbin
    [J]. International Journal of Impotence Research, 2004, 16 : S4 - S7
  • [25] Phosphodiesterase Type 5 (PDE5) Inhibitors in Erectile Dysfunction: The Proper Drug for the Proper Patient
    Corona, Giovanni
    Mondaini, Nicola
    Ungar, Andrea
    Razzoli, Elisa
    Rossi, Andrea
    Fusco, Ferdinando
    [J]. JOURNAL OF SEXUAL MEDICINE, 2011, 8 (12): : 3418 - 3432
  • [26] Pyrroloquinolone PDE5 inhibitors with improved pharmaceutical profiles for clinical studies on erectile dysfunction
    Jiang, WQ
    Guan, JH
    Macielag, MJ
    Zhang, SY
    Qiu, YH
    Kraft, P
    Bhattacharjee, S
    John, TM
    Haynes-Johnson, D
    Lundeen, S
    Sui, ZH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 2126 - 2133
  • [27] Furoyl and benzofuroyl pyrroloquinolones as potent and selective PDE5 inhibitors for treatment of erectile dysfunction
    Jiang, WQ
    Sui, ZH
    Macielag, MJ
    Walsh, SP
    Fiordeliso, JJ
    Lanter, JC
    Guan, JH
    Qiu, YH
    Kraft, P
    Bhattacharjee, S
    Craig, E
    Haynes-Johnson, D
    John, TM
    Clancy, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (03) : 441 - 444
  • [28] Current safety and tolerability issues in men with erectile dysfunction receiving PDE5 inhibitors
    Hellstrom, W. J. G.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (09) : 1547 - 1554
  • [29] Combining testosterone and PDE5 inhibitors in erectile dysfunction: Basic rationale and clinical evidences
    Greco, Emanuela A.
    Spera, Giovanni
    Aversa, Antonio
    [J]. EUROPEAN UROLOGY, 2006, 50 (05) : 940 - 947
  • [30] Continuous use of PDE5 inhibitors in the treatment of erectile dysfunction: New insights and opportunities
    Maria Puigvert, Ana
    Prieto, Rafael
    Garcia, Ferran
    [J]. REVISTA INTERNACIONAL DE ANDROLOGIA, 2018, 16 (01): : 28 - 33